SEC Company Response from HUTCHMED (China) Ltd (HCM, HMDCF) (CIK 0001648257) (HCM) — Mar 16, 2016
HUTCHMED (China) Ltd (HCM, HMDCF) (CIK 0001648257)
Date: March 16, 2016 · CIK: 0001648257 · Accession: 0001104659-16-105342
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-207447
Letter
Deutsche Bank Securities Inc. Merrill Lynch, Pierce, Fenner & Smith
Incorporated
As representatives of the several Underwriters named in Schedule A to the Underwriting Agreement
c/o Deutsche Bank Securities Inc. 60 Wall Street, 4th Floor, New York, New York 10005
c/o Merrill Lynch, Pierce, Fenner & Smith
Incorporated
One Bryant Park, New York, New York 10036
VIA EDGAR AND FACSIMILE
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention: Suzanne Hayes / Alexandra M. Ledbetter
Christine Torney / James Rosenberg
March 16, 2016
Re: Hutchison China MediTech Limited (the “Company”)
Registration Statement on Form F-1 (Registration File No. 333-207447)
Ladies and Gentlemen:
We hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:45 p.m. Eastern Daylight Time on March 16, 2016, or as soon thereafter as practicable.
Pursuant to Rule 460 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended, we wish to advise you that we have effected the following distribution of the Company’s preliminary prospectus dated March 4, 2016, through the date hereof:
Preliminary Prospectus dated March 4, 2016:
634 copies to prospective underwriters, institutional investors, dealers and others
The undersigned advise that the underwriters have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature Page follows]
Very truly yours,
As Representatives of the several
Show Raw Text
CORRESP 1 filename1.htm Deutsche Bank Securities Inc. Merrill Lynch, Pierce, Fenner & Smith Incorporated As representatives of the several Underwriters named in Schedule A to the Underwriting Agreement c/o Deutsche Bank Securities Inc. 60 Wall Street, 4th Floor, New York, New York 10005 c/o Merrill Lynch, Pierce, Fenner & Smith Incorporated One Bryant Park, New York, New York 10036 VIA EDGAR AND FACSIMILE Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Suzanne Hayes / Alexandra M. Ledbetter Christine Torney / James Rosenberg March 16, 2016 Re: Hutchison China MediTech Limited (the “Company”) Registration Statement on Form F-1 (Registration File No. 333-207447) Ladies and Gentlemen: We hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:45 p.m. Eastern Daylight Time on March 16, 2016, or as soon thereafter as practicable. Pursuant to Rule 460 of the General Rules and Regulations promulgated under the Securities Act of 1933, as amended, we wish to advise you that we have effected the following distribution of the Company’s preliminary prospectus dated March 4, 2016, through the date hereof: Preliminary Prospectus dated March 4, 2016: 634 copies to prospective underwriters, institutional investors, dealers and others The undersigned advise that the underwriters have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [Signature Page follows] Very truly yours, As Representatives of the several Underwriters Deutsche Bank Securities Inc. By: /s/ John Reed Name: John Reed Title: Managing Director By: /s/Isobel van Daesdonk Name: Isobel van Daesdonk Title: Managing Director Merill Lynch, Pierce, Fenner & Smith Incorporated By: /s/ Edmond Tin Name: Edmond Tin Title: Director